Seagen Inc. 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 4:20 pm Unchanged | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Seagen Inc. SGEN | 46,327 5.000% | 0 (Unchanged) | Filing |
| 2021-04-02 4:20 pm Purchase | 2021-03-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Seagen Inc. SGEN | 46,327 6.200% | 46,327 (New Position) | Filing |